Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Prev Med ; 57(3): 183-8, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23732247

RESUMO

OBJECTIVE: The present study assessed the effectiveness of smoking cessation programs combining individual and telephone counselling, compared to individual or telephone counselling alone. METHOD: A randomized, multicentre, open-label trial was performed between January 2009 and July 2011 at six smoking cessation clinics in Spain. Of 772 smokers assessed for eligibility, 600 (77%) met inclusion criteria and were randomized. Smokers were randomized to receive individual counselling, combined telephone and individual counselling, or telephone counselling. The primary outcome was biochemically validated continuous abstinence at 52 weeks. RESULTS: The 52-week abstinence rate was significantly lower in the telephone group compared to the combined group (20.1% vs. 29.0%; OR, 1.32; 95% CI, 1.1-2.7) and to the individual counselling group (20.1% vs. 27.9%; OR, 1.37; 95% CI, 1.0-2.8). The 52-week abstinence rates were not significantly higher in the combined group than the individual group (OR, 0.97; 95% CI, 0.7-1.4). CONCLUSION: Individual counselling and combined individual and telephone counselling were associated with higher 52-week abstinence rates than telephone counselling alone. A combined approach may be highly useful in the clinical treatment of smokers, as it involves less clinic visits than individual counselling alone, thus reducing the program cost, and it increases patient compliance compared to telephone counselling alone.


Assuntos
Aconselhamento Diretivo/organização & administração , Linhas Diretas , Abandono do Hábito de Fumar , Prevenção do Hábito de Fumar , Adulto , Benzazepinas/uso terapêutico , Bupropiona/uso terapêutico , Terapia Combinada , Inibidores da Captação de Dopamina/uso terapêutico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Agonistas Nicotínicos/uso terapêutico , Cooperação do Paciente , Quinoxalinas/uso terapêutico , Espanha , Telefone , Dispositivos para o Abandono do Uso de Tabaco , Resultado do Tratamento , Vareniclina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA